0001415889-24-020551.txt : 20240801 0001415889-24-020551.hdr.sgml : 20240801 20240801183433 ACCESSION NUMBER: 0001415889-24-020551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240731 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bowron Kimberly T CENTRAL INDEX KEY: 0001866673 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35073 FILM NUMBER: 241168320 MAIL ADDRESS: STREET 1: C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH STREET 2: BUILDING C, SUITE 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gevo, Inc. CENTRAL INDEX KEY: 0001392380 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 870747704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-858-8358 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Gevo Inc DATE OF NAME CHANGE: 20070307 4 1 form4-08012024_100829.xml X0508 4 2024-07-31 0001392380 Gevo, Inc. GEVO 0001866673 Bowron Kimberly T C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH BUILDING C, SUITE 310 ENGLEWOOD CO 80112 false true false false Chief People Officer 1 Common Stock 2024-07-31 4 S 0 10598 0.5897 D 435223 D Common Stock 17067.43 I By 401(k) Plan Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 25, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5800 to $0.5995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ E. Cabell Massey, Attorney-in-Fact 2024-08-01